Basal insulin and cardiovascular and other outcomes in dysglycemia

Hertzel C Gerstein, Jackie Bosch, Gilles R Dagenais, Rafael Díaz, Hyejung Jung, Aldo P Maggioni, Janice Pogue, Jeffrey Probstfield, Ambady Ramachandran, Matthew C Riddle, Lars E Rydén, Salim Yusuf, ORIGIN Trial Investigators, Thure Krarup, Hans Jørgen Duckert Perrild, Christian Tobias Torp-Pedersen

Abstract

The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.
OriginalsprogEngelsk
TidsskriftNew England Journal of Medicine
Vol/bind367
Udgave nummer4
Sider (fra-til)319-28
Antal sider10
ISSN0028-4793
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Basal insulin and cardiovascular and other outcomes in dysglycemia'. Sammen danner de et unikt fingeraftryk.

Citationsformater